Ads
related to: pharmaceuticals- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- ETF Education
View Our Educational Library to
Learn More About Our Products.
- Healthcare ETF
Search results
CASI Pharmaceuticals shares target cut by H.C.Waingwright on increased competition By Investing.com
Investing.com· 12 hours agoWednesday, an analyst from H.C. Wainwright adjusted the price target on shares of CASI ...
Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) Stock: Will It Keep Climbing Higher? – Marketing...
Marketing Sentinel· 10 hours agoIn the last trading session, 4.96 million shares of the Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) were traded, and its beta was 0.18. Most recently the company’s share price ...
Supernus Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.31 in 1Q 2023)
Simply Wall St. via Yahoo Finance· 6 days agoThe company's share price is broadly unchanged from a week ago. Balance Sheet Analysis Just as...
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
GuruFocus.com via Yahoo Finance· 10 hours agoCharles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased...
Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com
Investing.com· 14 hours agoIn a recent transaction, Alane P. Barnes, the Chief Legal Officer of Biocryst Pharmaceuticals Inc....
Q1 2024 NRX Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 hours agoParticipants Matthew Duffy; Chief Business Officer; NRx Pharmaceuticals, Inc. Stephen Willard; CEO; NRx Pharmaceuticals, Inc. Jonathan Javitt; Chairman ...
Earnings call: Teva Pharmaceuticals reports growth and pipeline progress By Investing.com
Investing.com· 6 days agoTeva Pharmaceuticals Industries Ltd. (TEVA) held its first quarter 2024 earnings conference call,...
Biocryst Pharmaceuticals CEO buys $166,500 in company stock By Investing.com
Investing.com· 14 hours agoIn a recent move that signals confidence in the company, Jon P. Stonehouse, the President and CEO of...
JD Supra: Reduction of EU regulatory data protection, but not as short as the European Commission...
JD Supra· 6 hours agoWith stated aims of making medicines more available, accessible, and affordable across the EU, the EU Pharmaceutical Law Package also seeks to support the competitiveness ...
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
Investor's Business Daily· 1 day agoOn Tuesday, Catalyst Pharmaceuticals stock hit an important technical milestone, with its Relative...
